57 results about "Intestinal gas" patented technology

The invention provides a compressed pharmaceutical composition comprising polyethylene glycol of molecular weight from 2000 to 4500, wherein the polyethylene glycol makes up from 80 to 99.5% by weight of the composition, one or more electrolytes for the treatment of constipation, faecal impaction, faecal retention, intestinal gas and cramping, or flatulence; or for orthostatic lavage, colon evacuation or colon cleansing. It has been found, surprisingly, that a compressed pharmaceutical composition comprising PEG for example a solid tablet, is significantly more palatable than previously proposed compositions and is effective when administered. The compressed pharmaceutical composition of the invention comprising polyethylene glycol has been found to have a more agreeable taste and a more agreeable mouthfeel than previously proposed liquid or dry powder or granular compositions.

The invention provides a compressed pharmaceutical composition comprising polyethylene glycol of molecular weight from 2000 to 4500, wherein the polyethylene glycol makes up from 80 to 99.5% by weight of the composition, one or more electrolytes for the treatment of constipation, faecal impaction, faecal retention, intestinal gas and cramping, or flatulence; or for orthostatic lavage, colon evacuation or colon cleansing. It has been found, surprisingly, that a compressed pharmaceutical composition comprising PEG for example a solid tablet, is significantly more palatable than previously proposed compositions and is effective when administered. The compressed pharmaceutical composition of the invention comprising polyethylene glycol has been found to have a more agreeable taste and a more agreeable mouthfeel than previously proposed liquid or dry powder or granular compositions.

An orally ingestible defecation deodarant reduces the production of intestinal gas and the production of malodors accompanying defecation or the emanation of intestinal gas, by absorbing malodor causing substances from the gastrointestinal tract; prevents the occurence of constipation; and adsorbs substances from the gastrointestinal tract that interfere with the absorption of orally administered drugs, pharmaceuticals, and other active ingredients from the gastrointestinal tract into the bloodstream and / or body. The defecation deodorant contains at least one adsorbent selected from a chelate compound, coconut vinegar, food fiber, gelatin, polyphenol, and a plant extract, on the surface of activated carbon.

The invention provides a production method of purple sweet potato residue dietary fibers, relates to the field of dietary fiber processing. The dietary fibers are processed from purple sweet potato residues, and the dietary fiber product quality is improved by the process of thinning purple sweet potato residue particles, homogenizing, performing high-pressure spray-drying and the like. According to the method, the purple sweet potato residues are used as a raw material for processing the purple sweet potato residue dietary fibers; the purpose of turning wastes into wealth is achieved; a product is rich in dietary fibers and good in quality, and can promote gastrointestinal motility, remove mucus, intestinal gas and septic matter retained in an enteric cavity, discharge toxic substances and cancerogenic substances in excrement, improve a digestive tract environment and prevent gastrointestinal diseases after being eaten often. A new path is opened for comprehensive development and utilization of potato residues and bean dregs, an environment protection effect is achieved, and the production method has high economic and beneficial benefits.

The present invention concerns solid compressed oral pharmaceutical compositions comprising a mixture of at least two sulphate salts selected from the group consisting of sodium, potassium and magnesium for use, in particular, in cleansing the colon or treating faecal impaction, constipation, faecal retention, intestinal gas and cramping, or flatulence in a mammal. Methods of producing such compositions are also disclosed.

Systems and methods have been developed for implementation of a portable SIBO testing system for convenient sampling of intestinal gases exhaled from a patient's breath. These devices may be in the form of a hand held meter that would integrate with a smartphone or other device with an application that can record data relating to food consumed by a user. Various technologies may be utilized to measure the levels of gases exhaled by a user, which may include (1) sorbent based technology and (2) membrane based technology. In some examples, the system will determine an indication of whether a patient has SIBO by adjusting a change in exhaled hydrogen concentration by a methane level exhaled by a patient.

The present invention relates to a composition comprising Bifidobacterium bacteria for use for reducing intestinal gas production in an individual.

The invention discloses a solid beverage rich in dietary fibers and plant-based sugar substitutes and a preparation method of the solid beverage, and belongs to the technical field of food processing.The solid beverage comprises the following raw materials in parts by mass: 50-80 parts of dietary fibers and 51-85 parts of sugar substitutes. The preparation method comprises the following steps: (1) weighing raw materials in parts by mass, dissolving the raw materials in water, uniformly mixing, and carrying out water bath ultrasonic embedding treatment to obtain a nano-scale particle embeddingmixed system; and (2) carrying out spray drying, and then carrying out superfine grinding to obtain a solid beverage product. According to the invention, self-assembly of nanoparticles is realized, so that the product can be released at a fixed point in the intestinal tract and absorbed efficiently after entering the digestive system of a human body, and the product is beneficial to digestion andabsorption of the human body through a superfine grinding process. After the product is eaten, the blood sugar can be controlled, intestinal flora can be effectively regulated, the growth of beneficial bacteria is promoted, the growth of harmful bacteria is inhibited, and the generation of intestinal gas is reduced.

The invention provides a low-residue nutritional formula product and a preparation method and application thereof. The product is not added with dietary fibers and is suitable for patients needing toundergo intestinal cleaning preparation for intestinal examination and intestinal surgery. The product contains protein, carbohydrate, fat, minerals and vitamins, marine fish oligopeptide with smallermolecular weight is adopted to replace collagen, nutrient ingredients which can be more easily absorbed are provided while ultralow residue is kept, and thereby, while the intestines are cleaned andthe production of intestinal gas is reduced, sufficient nutrition is provided for patients. Compared with the conventional intestinal cleaning method, the preparation method provided by the inventionhas the following advantages that the cleanliness of the intestines treated by the produced disclosed by the invention is high, the intestinal adenoma and polypus detection rate is high, the amount ofproduced gas is small, nutritional support is good, and the applicability to patients is high.

A method of treatment for intestinal gas bloating, microscopic colitis, traveler's diarrhea and inflammatory bowel disease, said method comprising ingesting an effective quantity of a composition comprising colloidal bismuth subcitrate to eliminate gastrointestinal discomfort.

The invention discloses a multi-layer multi-release metagen composition and application thereof in quickly promoting defecation, lubricating intestinal tracts, relieving intestinal problems such as flatulence, stomachache, diarrhea, constipation, irritable bowel syndrome and inflammatory bowel disease, maintaining intestinal flora balance, repairing intestinal tracts, repairing intestinal mucosa health, relieving dyspepsia and improving gastrointestinal functions.

Disclosed are the methods and compositions for the reduction of intestinal gas / flatulence. Specifically a method for reducing flatulence using a composition containing probiotic bacteria Bacillus coagulans MTCC 5856 is disclosed. More specifically, the invention discloses a method for inhibiting the growth of microorganisms that facilitate the production of intestinal gas, using a composition containing probiotic bacteria Bacillus coagulans MTCC 5856.

The invention relates to the technical field of image processing, in particular to an X-ray image processing system for enteritis prognosis analysis, which comprises the following steps of: obtaining a gray level image according to multi-threshold segmentation; obtaining the gray level fluctuation degree of the gray level image according to the histogram of the gray level image; determining a pixel point aggregation degree through connected domain analysis; obtaining an initial lesion probability by combining the gray level fluctuation degree and the pixel point aggregation degree of the gray level image; according to the fitting result of each gray level image, obtaining the probability of existence of intestinal tract gas; adjusting the initial lesion probability according to the intestinal tract gas probability to obtain the lesion probability; obtaining transformation parameters of the gray level image according to the lesion probability; linear transformation is conducted on the X-ray image according to the transformation parameters, and an enhanced intestinal tract X-ray image is obtained and visualized. The contrast ratio between a lesion area and the surroundings is enhanced, the visual effect of shadow caused by gas is weakened, and prognosis analysis of doctors is facilitated.

The invention provides a nutrition conveying method of a low-protein type total nutrient. According to the method for conveying the nutrient according to the intestinal gas amount of a microbiota, theintestinal gas amount of the microbiota related to a patient is monitored; the nutrient delivery amount delivered to the patient is controlled and / or the nutrient delivery rate is adjusted based on the relative change of the microbial community intestinal tract gas relative to the baseline value, so that the nutrient delivery is more scientific, and the absorption is more efficient. Besides, thelow-protein nutrient disclosed by the invention is scientific in formula, not only can reduce the intake of dietary protein to delay the loss of the residual kidney function of the patient, but also is beneficial to reducing the urine protein level of the patient and improving hyperphosphatemia, glycolipid metabolism and hypertension.

An embodiment of the invention discloses a method and a device for monitoring physical conditions of users. The method includes acquiring intestinal gas expelling information of users, sending the intestinal gas expelling information of users to a mobile terminal or server to allow the mobile terminal or server to analyze physical conditions of the users according to the intestinal gas expelling information of the users, receiving and displaying information of the physical conditions of users fed back by the mobile terminal or server to analyze gas components and expelling frequency, thereby analyzing problems of intestinal tract purposefully to further analyze current physical conditions of the users and then giving scientific dieting suggestions to prevent diseases of the intestinal tract. The information includes components of gases expelled by the users and intestinal gas expelling time of the users. Therefore, the method and the device for monitoring physical conditions of users have good effect in keeping physical health and controlling diseases of the intestinal tract at beginning stage.

Disclosed are the methods and compositions for the reduction of intestinal gas / flatulence. Specifically a method for reducing flatulence using a composition containing probiotic bacteria Bacillus coagulans MTCC 5856 is disclosed. More specifically, the invention discloses a method for inhibiting the growth of microorganisms that facilitate the production of intestinal gas, using a composition containing probiotic bacteria Bacillus coagulans MTCC 5856.

A defecating apparatus for removing intestinal obstruction is characterized in that a disposable catheter, a negative-pressure aspiration drum and a disposable infusion set are connected by a three-way pipe. The defecating apparatus is favorable for exhausting intestinal gas excretion and defecating, is convenient in operation, low in price, light in traumatic effect and free of repeated operation and effectively treats intestinal obstruction caused by rectostenosis.

The utility model discloses an intestinal pneumatosis discharging device, which belongs to the technical field of medical instruments and comprises a working tube, a negative pressure device and an injector, a suction channel and a liquid drainage channel are arranged in the working pipe and are arranged in the extending direction of the working pipe, a plurality of suction holes and a plurality of liquid drainage holes are formed in the pipe wall of the working pipe, the suction channel is communicated with the outside through the suction holes, and the liquid drainage channel is communicated with the outside through the liquid drainage holes; the negative pressure device is communicated with the suction channel; the syringe is a spiral push type syringe, the syringe is communicated with the liquid discharge channel, so that working liquid in the syringe can enter the outside through the liquid discharge channel and the multiple liquid discharge holes, and by means of the structure, the pressure reduction of the intestinal tract of a patient is helped, and meanwhile lubricating liquid and medicine can be injected into the intestinal tract according to the use requirements.

The invention provides a nutrition conveying method of child type total nutrients. According to the method for conveying nutrients according to microbiota intestinal gas amount, the microbiota intestinal gas amount related to a patient is monitored, the amount of nutrients delivered to the patient is controlled and / or the rate of nutrient delivery is adjusted based on a relative change, relative to baseline value, of the microbiota intestinal gas, so that the delivery of the nutrients is more scientific. In addition, the child type nutrient formula is specially researched and developed for children, and the nutrition is more balanced.

The invention discloses a making method of a health-preservation healthy food, relates to the field of healthy foods, and provides the health-preservation healthy food. The health-preservation healthyfood has the efficacy of alleviating deficiency, strengthening bodies, diminishing inflammation, sterilizing, preventing cancer, resisting cancer, invigorating the brain, preventing ageing, purifyingblood, reducing cholesterol, nourishing the liver, nourishing the kidney, nourishing the lung, promoting appetite, allaying tiredness, soothing the nerves, promoting circulation of qi and blood, depressing Qi, easing the intestines, clearing heat, eliminating swelling, eliminating wind pains, dispelling food retention and stagnation, clearing the intestines, moisturizing the intestines, easing constipation, relieving a cough, relieving asthma, resisting anaphylaxis, strengthening the heart, reducing weight, beautifying faces and the like.

The invention discloses a culture medium for colonization of intestinal flora and intestinal gas of gastrointestinal cancer crowds. The culture medium contains yeast extract, tryptone, mucoprotein, mycoprotein, insect protein, soybean protein, fructo-oligosaccharide, galactooligosaccharide, inulin, resistant dextrin, dietary fiber, porridge, vegetable juice, fruit juice, oat powder, coix seed powder, black bean powder, sialic acid, algal oil DHA, potassium chloride, sodium chloride, monopotassium phosphate, sodium sulfate, bile salt and a plant extract mixture. Vitamin mixed liquid and the like. By means of the bionic colon reactor, by referring to real in-vivo parameters of gastrointestinal cancer people, the real intestinal environment of domestic gastrointestinal cancer people is well simulated in vitro, the intestinal flora ecology and intestinal gas distribution are reproduced, and a normal intestinal microorganism and intestinal gas database of the gastrointestinal cancer people can be constructed. The method is beneficial to accurate diagnosis and personalized treatment of intestinal microecology of people with gastrointestinal cancer, and better evaluates the health state of people with gastrointestinal cancer and formulates preventive measures.

The invention provides a nutrition conveying method of a short peptide type full nutrient. According to the method for conveying the nutrients according to intestinal gas amount of microbiota, the intestinal gas amount of the microbiota related to a patient is monitored; the delivery amount of nutrients delivered to the patient is controlled and / or the nutrient delivery rate is adjusted based on the relative change of the microbiota intestinal gas relative to the baseline value, so that the nutrient delivery is more scientific, and the absorption is more efficient. In addition, the short peptide type nutrient is suitable for preoperative feeding of patients with malnutrition, and suitable for people with metabolic gastrointestinal dysfunction such as pancreatitis and people with critical diseases.

The invention discloses a culture medium for colonization of intestinal flora and intestinal gas of people with hyperuricemia. The culture medium contains yeast extract, ethanol, adenine, tryptone, mucoprotein, mycoprotein, insect protein, soybean protein, fructose, glucose, inulin, resistant dextrin, dietary fiber, oxalic acid, saturated fatty acid, sialic acid, peanut oil, potassium chloride, sodium chloride, monopotassium phosphate, sodium sulfate, bile salt, cysteine hydrochloride and a plant extract mixture. Vitamin mixed liquid and the like. By means of the bionic colon reactor, by referring to real in-vivo parameters of people suffering from hyperuricemia, the real intestinal environment of people suffering from hyperuricemia in China is well simulated in vitro, the intestinal flora ecology and intestinal gas distribution are reproduced, and a normal intestinal microorganism and intestinal gas database of people suffering from hyperuricemia can be constructed. The method is beneficial to accurate diagnosis of intestinal microecology of people with hyperuricemia, individualized treatment of antisense booking and disease mechanisms, better maintenance of intestinal health and formulation of preventive measures.

The present application belongs to the technical field of medium-chain fatty acid triglyceride performance improvement, and particularly relates to a method for improving the sustained-release performance of medium-chain fatty acid triglyceride. The method of the present application is to prepare the medium-chain fatty acid triglyceride into microcapsules to improve its sustained-release performance, so as to avoid the occurrence of diarrhea and intestinal gas and other intestinal diseases caused by excessive one-time intake stimulating the gastrointestinal tract. The specific operation is as follows: taking whey protein and inulin as the composite wall material, taking medium-chain fatty acid triglyceride as the core material, emulsifying under the action of the compounded emulsifier, and adopting the spray drying method to prepare into microcapsules, wherein the weight ratio of the whey protein to the inulin is 2.87:1. The prepared microcapsules have a microcapsule embedding rate of 96.25%, and the in-vitro simulated gastrointestinal tract digestion release rate is 84.53%, so that the release in the gastrointestinal tract is delayed. In addition, the addition of inulin in the microcapsule wall material can meet the needs of diabetic patients, and further provides the storage stability.

Systems and methods have been developed for implementation of a portable SIBO testing system for convenient sampling of intestinal gases exhaled from a patient's breath. These devices may be in the form of a hand held meter that would integrate with a smartphone or other device with an application that can record data relating to food consumed by a user. Various technologies may be utilized to measure the levels of gases exhaled by a user, which may include (1) sorbent based technology and (2) membrane based technology. In some examples, the system will determine an indication of whether a patient has SIBO by adjusting a change in exhaled hydrogen concentration by a methane level exhaled by a patient.

The invention relates to a traditional Chinese medicine for treating pneumatosis cystoids intestinalis. The traditional Chinese medicine is prepared from the following medicinal materials in parts by weight: 8 parts of fructus rosae laevigatae, 9 parts of processed semen strychni, 14 parts of pericarpium citri reticulatae, 6 parts of root of Chinese thorowax, 10 parts of rhizoma anemarrhenae, 12 parts of asparagus cochinchinensis, 15 parts of rhizoma polygonati odorati, 6 parts of gecko, 1 part of cordyceps sinensis, 14 parts of catsia tora linn, 9 parts of cortex lycii radicis, 10 parts of polygonum multiflorum, 8 parts of lilium brownie and 8 parts of cuttlebone. Clinical experiments show that the traditional Chinese medicine can safely and effectively treat pneumatosis cystoids intestinalis.

This invention relates to the field of microbial technology, and particularly to a compound probiotic agent for reducing the production of harmful intestinal gases and regulating intestinal flora. The compound probiotic of this invention consists of *Bifidobacterium animalis* subsp. *lactobacter* Bi66, *Lactobacillus plantarum* P16, and *Saccharomyces boulardii* strain Bld-3. This invention combines these three strains to significantly increase the content of short-chain fatty acids in the intestinal flora, increase the production of beneficial gases such as CH4 and H2, and reduce the production of harmful gases such as NH3 and H2S, thereby promoting the growth of beneficial bacteria and inhibiting the growth of harmful bacteria and regulating the intestinal flora. While maintaining a consistent amount of bacteria, compared with intervention methods lacking any one of the strains, the combination of the three strains showed the best effect in improving the intestinal flora, indicating that the three strains can cooperate and promote each other, and can synergistically enhance the effect in regulating the intestinal flora.

The invention discloses a black soya bean and licorice root healthy drink.The black soya bean and licorice root healthy drink is prepared from, by weight, 100 parts of black soya bean, 20 parts of licorice root, 20 parts of radix astragali and 30 parts of apricot kernel.The invention further provides an extracting preparing method and a baking preparing method of the black soya bean and licorice root healthy drink.Radix astragali is used for providing intestinal gas, apricot kernel is used for guiding large intestine gas to move downwards, and toxicity brought out by means of black soya bean and licorice root is discharged out of the body in time.By taking the drink, the body works in a unique mode, downward movement is achieved, reverse ascending is avoided, digestion is achieved, stagnancy is avoided, the health condition of people who take the drink is improved, and the effects of balancing yin and yang, promoting blood and qi circulation and refreshing are realized; furthermore, the drink is convenient to package and take.The preparing method is easy to operate, and the efficacy and nutrient ingredients of each component can be well reserved.

The invention discloses a medicine for treating hernia and a preparation method thereof. The medicine is made of the following raw materials in parts by weight: 10-15 parts of Shuangshencao, 8-10 parts of fennel, 8-10 parts of Cyperus cyperi, 2-5 parts of Evodia rutaecarpa, 2-5 parts of cinnamon, 3-6 parts of Divine Comedy. The combination of these medicines makes the efficacy of each medicine produce a synergistic effect, thereby effectively treating the hernia, with remarkable and stable curative effect, no recurrence after cure, no toxic and side effects, and low price. The medicament of the present invention also has the effects of treating indigestion and gas in children, intestinal gas in men and women, fullness in the lower abdomen, dyspepsia, lack of appetite, and the like.